Jump to content

Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes (Q73846452)

From Wikidata

scientific article published on 01 October 1997

Language	Label	Description	Also known as
default for all languages	No label defined
English	Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes	scientific article published on 01 October 1997

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357387%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357387%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Reginald F. Frye

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357387%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Matzke GR

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357387%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Adedoyin A

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357387%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Porter JA

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357387%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Branch RA

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357387%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 October 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357387%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357387%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

62

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357387%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357387%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

365-376

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357387%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Liver blood flow, antipyrine clearance, and antipyrine metabolite formation clearance in patients with chronic active hepatitis and alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Influence of diet and nutritional status on drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Assessment of liver metabolic function. Clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

A 'cocktail' strategy to assess in vivo oxidative drug metabolism in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Interindividual variations in drug disposition. Clinical implications and methods of investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Single-dose disulfiram inhibition of chlorzoxazone metabolism: a clinical probe for P450 2E1

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Frequency distribution of dapsone N-hydroxylase, a putative probe for P4503A4 activity, in a white population

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

The genetic polymorphism of debrisoquine/sparteine metabolism-molecular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Genetic polymorphism of S-mephenytoin hydroxylation

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

The disposition of dapsone in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Activity of oxidative routes of metabolism of debrisoquin, mephenytoin, and dapsone is unrelated to the pathogenesis of vinyl chloride-induced disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Simplified phenotyping with dextromethorphan by thin-layer chromatography: application to clinical laboratory screening for deficiencies in oxidative drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Scleroderma is associated with differences in individual routes of drug metabolism: a study with dapsone, debrisoquin, and mephenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Determination of chlorzoxazone and 6-hydroxychlorzoxazone in human plasma and urine by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

The contribution of N-hydroxylation and acetylation to dapsone pharmacokinetics in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Improved high-performance liquid chromatographic determination of debrisoquine and 4-hydroxydebrisoquine in human urine following direct injection

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

High-performance liquid chromatographic determination of chlorzoxazone and 6-hydroxychlorzoxazone in serum: a tool for indirect evaluation of cytochrome P4502E1 activity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo*

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

N-Hydroxylation of dapsone by multiple enzymes of cytochrome P450: implications for inhibition of haemotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Quinidine: potent inhibition of sparteine and debrisoquine oxidation in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Pharmacokinetics and metabolism of quinidine in extensive and poor metabolisers of sparteine

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Relationship between the metabolism of antipyrine, hexobarbital and theophylline in patients with liver disease as assessed by a 'cocktail' approach

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Relationship between the metabolism of antipyrine, hexobarbitone and theophylline in man as assessed by a 'cocktail' approach

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Effects of interferon-alpha monotherapy on hepatic drug metabolism in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Metronidazole and antipyrine as probes for the study of foreign compound metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Influence of renal failure on cytochrome P 450 activity in hypertensive patients using a "cocktail" of antipyrine and nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

The relationship between phenazone (antipyrine) metabolite formation and theophylline metabolism in healthy and frail elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Selective inhibition of drug oxidation after simultaneous administration of two probe drugs, antipyrine and tolbutamide

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in children

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Comparison of hepatic drug-oxidizing activity after simultaneous administration of two probe drugs, caffeine and trimethadione, to human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Dapsone N-acetylation, metoprolol alpha-hydroxylation, and S-mephenytoin 4-hydroxylation polymorphisms in an Indonesian population: a cocktail and extended phenotyping assessment trial

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

S-mephenytoin hydroxylation phenotypes in a Swedish population determined after coadministration with debrisoquin

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Effects of ketoconazole on the polymorphic 4-hydroxylations of S-mephenytoin and debrisoquine

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Rapid screening for polymorphisms in dextromethorphan and mephenytoin metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Differential effects of quinidine on the disposition of nifedipine, sparteine, and mephenytoin in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Lack of pharmacokinetic interaction between nifedipine, sparteine and phenytoin in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Cocktail strategy: complications and limitations

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

The ability to 4-hydroxylate debrisoquine is related to recurrence of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

Interaction between two probes used for phenotyping cytochromes P4501A2 (caffeine) and P4502E1 (chlorzoxazone) in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990114-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0009-9236(97)90114-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357387%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357387%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73846452&oldid=2224699521"